Key Points Q2 revenue of $2.76 billion and adjusted EPS of $2.62 beat analyst estimates. Management raised full-year 2025 guidance for both revenue and adjusted EPS, supported by strong operational ...

Davis reported double-digit revenue growth in advanced diagnostics, particularly in cardiometabolic, autoimmune, and brain health, as well as ramping commercial outreach for the Haystack MRD oncology ...

Laboratory operator Quest Diagnostics raised its 2025 profit and revenue forecasts on Tuesday, banking on robust demand for its diagnostic tests, sending the company's shares up over 3% in premarket ...